Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adults.

Cheryl CarcelLauren ClancyKatie HarrisRuth PetersAisling ByrneKimberley BassettRuth FreedCamilla M HoyosAnthony RodgersRichard I LindleyJohn ChalmersYing XuMark WoodwardMenglu OuyangSharon L NaismithCraig Anderson

Published in: BMJ open (2024)

Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12621000121864.

Keyphrases

cognitive decline
clinical trial
low dose
study protocol
phase ii
phase iii
mild cognitive impairment
blood pressure
open label
high dose
randomized controlled trial
double blind
hypertensive patients
adverse drug
drug induced
placebo controlled
emergency department